Rabi Hanna, MD

Hanna explains the real-world barriers to implementing gene editing therapies in sickle cell disease.

Hanna describes the "freedom" patients with sickle cell disease reported after being treated with reni-cel, a one-time edited gene therapy.

Hanna, MD, shares results from reni-cel, a one-time gene editing therapy for patients with sickle cell disease.